APO Research
Talk to an analyst

APO RESEARCH · REPORT

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Growth and Trends Forecast to 2032

22 December 2025116 pages

Choose your research edition.

Industry ResearchPorcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines include CAHIC, Agrovet, Bioveta, Boehringer Ingelheim, CAVAC, Ceva, DHN, Komipharm and MSD Animal Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market size, estimates, and forecasts are presented in terms of sales volume (m units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market by Company

CAHIC

Agrovet

Bioveta

Boehringer Ingelheim

CAVAC

Ceva

DHN

Komipharm

MSD Animal Health

Phibro Animal Health

PULILE

Ringpu Biology

Tecon

WINSUN

ChengDu Tecbond

Sino Pharm

Jinyu Bio-Technology

Qilu Animal

Zoetis

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Type

Live Vaccines

Killed Vaccines

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Application

Government Tender

Market Sales

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Live Vaccines Table 2. Major Company of Killed Vaccines Table 3. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2026) & (m units) Table 5. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Type (2021-2026) Table 6. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2026) & (US$ Million) Table 7. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Type (2021-2026) Table 8. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2021-2026) & (US$/k unit) Table 9. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2027-2032) & (m units) Table 10. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Type (2027-2032) Table 11. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2027-2032) & (US$ Million) Table 12. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Type (2027-2032) Table 13. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2027-2032) & (US$/k unit) Table 14. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2026) & (m units) Table 15. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2026) & (m units) Table 17. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2026) & (m units) Table 19. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2026) & (m units) Table 21. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2026) & (m units) Table 23. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Trends Table 25. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Drivers Table 26. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Opportunities and Challenges Table 27. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Restraints Table 28. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Company (2021-2026) Table 30. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Company (2021-2026) & (m units) Table 31. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Share by Company (2021-2026) Table 32. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Price by Company (2021-2026) & (US$/k unit) Table 33. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Major Company Production Sites and Headquarters Table 35. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Company, Product Type & Application Table 36. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2021-2026) & (m units) Table 41. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Region (2021-2026) Table 42. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2021-2026) & (US$ Million) Table 43. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Region (2021-2026) Table 44. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 45. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2027-2032) & (m units) Table 46. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Region (2027-2032) Table 47. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2027-2032) & (US$ Million) Table 48. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Region (2027-2032) Table 49. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2027-2032) Table 50. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2026) & (m units) Table 52. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Application (2021-2026) Table 53. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2026) & (US$ Million) Table 54. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Application (2021-2026) Table 55. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2021-2026) & (US$/k unit) Table 56. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2027-2032) & (m units) Table 57. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Application (2027-2032) Table 58. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2027-2032) & (US$ Million) Table 59. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Application (2027-2032) Table 60. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2027-2032) & (US$/k unit) Table 61. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2026) & (m units) Table 62. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2026) & (m units) Table 64. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2026) & (m units) Table 66. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2026) & (m units) Table 68. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2026) & (m units) Table 70. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. CAHIC Company Information Table 72. CAHIC Business Overview Table 73. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 74. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 75. CAHIC Recent Development Table 76. Agrovet Company Information Table 77. Agrovet Business Overview Table 78. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 79. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 80. Agrovet Recent Development Table 81. Bioveta Company Information Table 82. Bioveta Business Overview Table 83. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 84. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 85. Bioveta Recent Development Table 86. Boehringer Ingelheim Company Information Table 87. Boehringer Ingelheim Business Overview Table 88. Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 89. Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 90. Boehringer Ingelheim Recent Development Table 91. CAVAC Company Information Table 92. CAVAC Business Overview Table 93. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 94. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 95. CAVAC Recent Development Table 96. Ceva Company Information Table 97. Ceva Business Overview Table 98. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 99. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 100. Ceva Recent Development Table 101. DHN Company Information Table 102. DHN Business Overview Table 103. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 104. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 105. DHN Recent Development Table 106. Komipharm Company Information Table 107. Komipharm Business Overview Table 108. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 109. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 110. Komipharm Recent Development Table 111. MSD Animal Health Company Information Table 112. MSD Animal Health Business Overview Table 113. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 114. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 115. MSD Animal Health Recent Development Table 116. Phibro Animal Health Company Information Table 117. Phibro Animal Health Business Overview Table 118. Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 119. Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 120. Phibro Animal Health Recent Development Table 121. PULILE Company Information Table 122. PULILE Business Overview Table 123. PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 124. PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 125. PULILE Recent Development Table 126. Ringpu Biology Company Information Table 127. Ringpu Biology Business Overview Table 128. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 129. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 130. Ringpu Biology Recent Development Table 131. Tecon Company Information Table 132. Tecon Business Overview Table 133. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 134. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 135. Tecon Recent Development Table 136. WINSUN Company Information Table 137. WINSUN Business Overview Table 138. WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 139. WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 140. WINSUN Recent Development Table 141. ChengDu Tecbond Company Information Table 142. ChengDu Tecbond Business Overview Table 143. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 144. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 145. ChengDu Tecbond Recent Development Table 146. Sino Pharm Company Information Table 147. Sino Pharm Business Overview Table 148. Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 149. Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 150. Sino Pharm Recent Development Table 151. Jinyu Bio-Technology Company Information Table 152. Jinyu Bio-Technology Business Overview Table 153. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 154. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 155. Jinyu Bio-Technology Recent Development Table 156. Qilu Animal Company Information Table 157. Qilu Animal Business Overview Table 158. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 159. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 160. Qilu Animal Recent Development Table 161. Zoetis Company Information Table 162. Zoetis Business Overview Table 163. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 164. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 165. Zoetis Recent Development Table 166. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 167. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026) & (m units) Table 168. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2021-2026) Table 169. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecast by Country (2027-2032) & (m units) Table 170. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share Forecast by Country (2027-2032) Table 171. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 173. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Country (2021-2026) Table 174. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share Forecast by Country (2027-2032) Table 176. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 177. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026) & (m units) Table 178. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2021-2026) Table 179. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecast by Country (2027-2032) & (m units) Table 180. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share Forecast by Country (2027-2032) Table 181. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 183. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Country (2021-2026) Table 184. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share Forecast by Country (2027-2032) Table 186. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 187. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026) & (m units) Table 188. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2021-2026) Table 189. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecast by Country (2027-2032) & (m units) Table 190. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 193. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Country (2021-2026) Table 194. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share Forecast by Country (2027-2032) Table 196. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 197. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026) & (m units) Table 198. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2021-2026) Table 199. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecast by Country (2027-2032) & (m units) Table 200. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share Forecast by Country (2027-2032) Table 201. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 203. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Country (2021-2026) Table 204. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share Forecast by Country (2027-2032) Table 206. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 207. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026) & (m units) Table 208. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2021-2026) Table 209. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecast by Country (2027-2032) & (m units) Table 210. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 213. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Country (2021-2026) Table 214. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share Forecast by Country (2027-2032) Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors List Table 219. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Image Figure 2. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (2021-2032) & (m units) Figure 5. Live Vaccines Image Figure 6. Global Live Vaccines Sales YoY Growth (2021-2032) & (m units) Figure 7. Killed Vaccines Image Figure 8. Global Killed Vaccines Sales YoY Growth (2021-2032) & (m units) Figure 9. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Type 2025 VS 2032 Figure 11. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Type in 2025 Figure 12. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Type in 2025 Figure 13. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Government Tender Image Figure 24. Global Government Tender Sales YoY Growth (2021-2032) & (m units) Figure 25. Market Sales Image Figure 26. Global Market Sales Sales YoY Growth (2021-2032) & (m units) Figure 27. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Application 2025 VS 2032 Figure 29. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Application in 2025 Figure 30. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Application in 2025 Figure 31. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Application in 2025 Figure 32. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Application in 2025 Figure 39. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 40. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 44. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 48. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 52. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 56. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Live Vaccines
  • Killed Vaccines
Applications
  • Government Tender
  • Market Sales
Companies covered
  • CAHIC
  • Agrovet
  • Bioveta
  • Boehringer Ingelheim
  • CAVAC
  • Ceva
  • DHN
  • Komipharm
  • MSD Animal Health
  • Phibro Animal Health
  • PULILE
  • Ringpu Biology
  • Tecon
  • WINSUN
  • ChengDu Tecbond
  • Sino Pharm
  • Jinyu Bio-Technology
  • Qilu Animal
  • Zoetis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market by Type
  6. 1.3.1 Live Vaccines
  7. 1.3.2 Killed Vaccines
  8. 1.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Type
  9. 1.4.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Trends
  2. 2.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Drivers
  3. 2.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Opportunities and Challenges
  4. 2.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price (2021-2026)
  4. 3.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Company, Product Type & Application
  7. 3.7 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Tier 1, Tier 2, and Tier 3
4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Regional Status and Outlook
  1. 4.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historic Market Size by Region
  3. 4.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Application
  1. 5.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market by Application
  2. 5.1.1 Government Tender
  3. 5.1.2 Market Sales
  4. 5.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Application
  5. 5.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CAHIC
  2. 6.1.1 CAHIC Company Information
  3. 6.1.2 CAHIC Business Overview
  4. 6.1.3 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  6. 6.1.5 CAHIC Recent Developments
  7. 6.2 Agrovet
  8. 6.2.1 Agrovet Company Information
  9. 6.2.2 Agrovet Business Overview
  10. 6.2.3 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  12. 6.2.5 Agrovet Recent Developments
  13. 6.3 Bioveta
  14. 6.3.1 Bioveta Company Information
  15. 6.3.2 Bioveta Business Overview
  16. 6.3.3 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  18. 6.3.5 Bioveta Recent Developments
  19. 6.4 Boehringer Ingelheim
  20. 6.4.1 Boehringer Ingelheim Company Information
  21. 6.4.2 Boehringer Ingelheim Business Overview
  22. 6.4.3 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  24. 6.4.5 Boehringer Ingelheim Recent Developments
  25. 6.5 CAVAC
  26. 6.5.1 CAVAC Company Information
  27. 6.5.2 CAVAC Business Overview
  28. 6.5.3 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  30. 6.5.5 CAVAC Recent Developments
  31. 6.6 Ceva
  32. 6.6.1 Ceva Company Information
  33. 6.6.2 Ceva Business Overview
  34. 6.6.3 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  36. 6.6.5 Ceva Recent Developments
  37. 6.7 DHN
  38. 6.7.1 DHN Company Information
  39. 6.7.2 DHN Business Overview
  40. 6.7.3 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  42. 6.7.5 DHN Recent Developments
  43. 6.8 Komipharm
  44. 6.8.1 Komipharm Company Information
  45. 6.8.2 Komipharm Business Overview
  46. 6.8.3 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  48. 6.8.5 Komipharm Recent Developments
  49. 6.9 MSD Animal Health
  50. 6.9.1 MSD Animal Health Company Information
  51. 6.9.2 MSD Animal Health Business Overview
  52. 6.9.3 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  54. 6.9.5 MSD Animal Health Recent Developments
  55. 6.10 Phibro Animal Health
  56. 6.10.1 Phibro Animal Health Company Information
  57. 6.10.2 Phibro Animal Health Business Overview
  58. 6.10.3 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  60. 6.10.5 Phibro Animal Health Recent Developments
  61. 6.11 PULILE
  62. 6.11.1 PULILE Company Information
  63. 6.11.2 PULILE Business Overview
  64. 6.11.3 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  66. 6.11.5 PULILE Recent Developments
  67. 6.12 Ringpu Biology
  68. 6.12.1 Ringpu Biology Company Information
  69. 6.12.2 Ringpu Biology Business Overview
  70. 6.12.3 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  72. 6.12.5 Ringpu Biology Recent Developments
  73. 6.13 Tecon
  74. 6.13.1 Tecon Company Information
  75. 6.13.2 Tecon Business Overview
  76. 6.13.3 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  78. 6.13.5 Tecon Recent Developments
  79. 6.14 WINSUN
  80. 6.14.1 WINSUN Company Information
  81. 6.14.2 WINSUN Business Overview
  82. 6.14.3 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  84. 6.14.5 WINSUN Recent Developments
  85. 6.15 ChengDu Tecbond
  86. 6.15.1 ChengDu Tecbond Company Information
  87. 6.15.2 ChengDu Tecbond Business Overview
  88. 6.15.3 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  90. 6.15.5 ChengDu Tecbond Recent Developments
  91. 6.16 Sino Pharm
  92. 6.16.1 Sino Pharm Company Information
  93. 6.16.2 Sino Pharm Business Overview
  94. 6.16.3 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  96. 6.16.5 Sino Pharm Recent Developments
  97. 6.17 Jinyu Bio-Technology
  98. 6.17.1 Jinyu Bio-Technology Company Information
  99. 6.17.2 Jinyu Bio-Technology Business Overview
  100. 6.17.3 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  102. 6.17.5 Jinyu Bio-Technology Recent Developments
  103. 6.18 Qilu Animal
  104. 6.18.1 Qilu Animal Company Information
  105. 6.18.2 Qilu Animal Business Overview
  106. 6.18.3 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  108. 6.18.5 Qilu Animal Recent Developments
  109. 6.19 Zoetis
  110. 6.19.1 Zoetis Company Information
  111. 6.19.2 Zoetis Business Overview
  112. 6.19.3 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  114. 6.19.5 Zoetis Recent Developments
7 North America by Country
  1. 7.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country
  2. 7.1.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country
  6. 7.2.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country
  2. 8.1.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country
  6. 8.2.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country
  2. 10.1.1 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country
  6. 10.2.1 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Value Chain Analysis
  2. 12.1.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production Mode & Process
  7. 12.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors
  10. 12.2.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst